PCT vs Paris Route: Which Foreign Filing Strategy Should You Use?

Overview

What this page helps you decide

If you’ve filed (or are about to file) a first patent application, the next big question is often: should you file abroad using the Paris Convention route, or use the PCT route?

This page helps you choose a foreign filing strategy that matches your business reality, including:

how soon you need protection in specific countries
how certain you are about target markets
how much time you need before committing major spend
how investors, partners, or competitors may influence timing

What “Paris route” means

The Paris Convention route is a straightforward approach:

you file a first application (often in your home country)
you then file in other countries within a strict window, typically 12 months from that first filing date (your “priority date”)

In simple terms, Paris route is “choose your countries early and file them within 12 months.”

What “PCT route” means

The PCT route starts with one international filing (the PCT application) that keeps many country options open for longer.

you still start with a first filing date (priority)
within 12 months, you file a PCT application
after that, you delay most country-by-country filings until later (often around 30/31 months from the priority date, depending on the country)

In simple terms, PCT is “delay country selection and major costs while keeping options open.”

What you should know upfront

There is no “world patent.” Both routes end in country-by-country patents.
Both routes rely heavily on your first filing date and what you disclosed in that first filing.
The “best” route is not universal. It depends on your market clarity, copying risk, budget, and timing.

The core difference (in one minute)

PCT vs Paris route (at a glance)

Factor	Paris route	PCT route	What it means for you
When you choose countries	Within 12 months	Later (often ~30/31 months from priority, country-dependent)	If markets are unclear, PCT reduces “wrong country” risk.
When major costs hit	Earlier (multiple filings + translations sooner)	Later (bigger spike at national phase)	PCT helps stage spend; Paris requires early budget readiness.
Speed to local processing	Earlier	Often later	If you need early local progress, Paris is usually more direct.
Flexibility	Lower after 12 months	Higher until national phase	PCT is better if strategy may change with traction or partners.
Administrative complexity timing	Complexity starts early	Complexity starts later	PCT delays multi-country coordination workload.

Decision first: what is your goal?

Why your goal matters more than the route

Many founders pick a route based on what they heard is “standard.” A better approach is to decide based on what you are trying to achieve.

Ask yourself: what would success look like in the next 12–24 months?

Goal: protect a few known countries as soon as possible

This goal usually fits when:

you already know your top 2–5 revenue markets
you are entering specific countries now (not “someday”)
you have a clear competitor risk in particular jurisdictions
you want local proceedings to start earlier

In these situations, Paris route is often a practical fit because it forces early decisions and starts local timelines sooner.

Goal: keep options open while you validate markets

This goal usually fits when:

you are unsure where the paying markets will be
you expect the business to pivot or refine the product
your strategy depends on partners or distribution that may change
you want to delay large costs until after milestones

In these situations, PCT route often fits because it preserves flexibility and delays the biggest spend.

Goal: manage cashflow and reduce “wrong country” mistakes

For many startups, the main risk is not “missing patents.” It’s spending heavily in countries that never become relevant.

If your biggest concern is avoiding expensive mistakes, PCT route often provides more room to make better decisions later.

Goal: meet investor, partner, or buyer expectations

Sometimes the route is influenced by external expectations:

investors may want to see a clear international strategy
corporate partners may prefer strong defensibility in key markets
acquirers may look for coverage aligned with revenue geographies

In these cases:

Paris route can signal focus (clear countries, earlier local filings)
PCT route can signal optionality (keeping multiple markets open while scaling)

Goal: handle competitor pressure

If a competitor is moving fast in a specific market, speed and certainty matter.

Paris route can be useful when you need early entry into a particular jurisdiction.
PCT route can still work, but you may need a tighter plan for which countries you will eventually enter.

Quick route selector

Choose Paris route more often when most of these are true:

you know the countries you need
you need earlier local filings
you have budget for multi-country filing within 12 months
your invention definition is stable now

Choose PCT route more often when most of these are true:

you need time to learn which countries matter
budget needs to be staged
the product may evolve
you want to delay large translation and local counsel costs

Paris route explained

How the Paris route works

The Paris route is built around one key concept: the priority date.

A typical flow looks like this:

You file a first patent application (this sets the priority date).
Within 12 months of that date, you file in foreign countries you choose.
Each chosen country’s patent office examines your application under its local rules.

The important point: you must decide your foreign country list within that 12-month window.

What makes the Paris route attractive

The Paris route can be a strong fit when you have clarity and want speed.

Common advantages:

Earlier start in chosen countries
Local filings happen sooner, so prosecution timelines begin earlier.
Strong focus
You commit only where you genuinely need protection, if you choose wisely.
Simpler strategic narrative
For some businesses, “we filed in our top markets” is a clean story.

When the Paris route usually fits best

Paris route tends to fit well when:

you know your top target markets with confidence
Example: you already sell or will sell in specific countries soon.
your product and invention scope are stable
The core invention is unlikely to change dramatically in the next year.
your business needs earlier local progress
Example: regulated procurement, tenders, enterprise diligence, licensing discussions.
your country list is small and intentional
Usually 2–5 countries rather than 10–20.

When the Paris route can be risky

Paris route becomes risky when the 12-month decision is made without enough information.

Common risk situations:

you don’t know where you’ll actually sell
Filing everywhere “just in case” can become costly quickly.
you have not tested copying risk by market
Not all countries matter equally for enforcement or deterrence.
budget is tight
Multi-country filing within 12 months can strain cashflow, especially with translations and counsel.
your invention is still evolving
Filing too early and too narrowly can lock you into a version that you don’t end up commercializing.

Common pitfalls to avoid

Waiting too long and rushing decisions
Many teams realize late that the 12-month deadline is near and pick countries without a strategy.
Picking countries based on popularity rather than business logic
“Big market” is not always “your market.”
Ignoring manufacturing and competitor geography
Revenue markets matter, but so do places where copying can scale.
Underestimating the cost of multiple local filings
Translation, formalities, attorney costs, and future prosecution can add up.

Practical takeaway for founders

Paris route works best when you can answer three questions clearly:

Which countries matter, and why?
What business outcome will patents support in those countries?
Can you fund not only filing, but also follow-through (responses, amendments, renewals)?

If you cannot answer these yet, the PCT route often becomes the more forgiving strategy because it buys decision time.

PCT route explained

How the PCT route works

The PCT route is designed to give you more time before you commit to expensive, country-by-country filings.

A typical flow looks like this:

You file a first patent application (this sets the priority date).
Within 12 months of that first filing, you file a PCT application.
During the international phase, you receive an international search report and written opinion (in most cases).
Later, you enter national phase in the countries you choose (often around 30/31 months from the priority date, depending on the country).

The important point: you do not avoid national filings. You delay and plan them.

What makes the PCT route attractive

The PCT route is often chosen for flexibility and better decision timing.

Common advantages:

More time to validate markets
You can use the extra months to learn which countries will actually matter.
More time to refine the invention and claim strategy
The search results can inform how to position the invention against prior art.
Budget staging
You can delay major translation and multi-counsel costs until you are closer to traction or funding.
Cleaner global story early
A PCT filing can signal international intent without forcing immediate country commitments.

When the PCT route usually fits best

PCT route tends to fit well when:

you are still discovering which markets will pay
This is common for new categories, platforms, or enterprise solutions.
you expect the product to evolve in the next year
You want your filing strategy to account for versions and variations.
you need to conserve cash in the first 12 months
You may prefer to spend on product and traction first.
you want optionality for partners, investors, or licensing
The ability to later select countries can be helpful in negotiations.

Common misunderstandings about PCT

A PCT filing is not a substitute for national filings.
You still need to enter national phase to obtain enforceable rights.
PCT does not automatically protect you everywhere.
It is a coordinated process, not a worldwide grant.
PCT does not remove prosecution effort.
Most effort still happens at the country level later.

Practical takeaway

PCT route is most valuable when you will actually use the extra time to make smarter decisions. If you will not do market validation, competitor mapping, or budget planning in the extra months, the benefit reduces.

Side-by-side comparison

Timeline checkpoints

Paris route:

Country list is locked within 12 months.
National filings happen early.
Local examination can start sooner in chosen countries.

PCT route:

PCT filed within 12 months.
International search/opinion usually arrives during the international phase.
National phase decisions happen later, closer to 30/31 months from priority in many cases.

Cashflow and cost spikes

Paris route:

Higher early spend if you file in multiple countries within 12 months.
Costs include multiple filing fees, translations (where needed), and local counsel.
Prosecution costs begin sooner in each country.

PCT route:

PCT adds cost, but can delay large multi-country filing costs.
The biggest cost spike often comes at national phase entry.
Prosecution costs shift later, which may align better with funding or revenue.

Administrative complexity

Paris route:

Multiple parallel filings early.
You manage deadlines and counsel across countries sooner.

PCT route:

One coordinated international step first.
Country-by-country complexity appears later, at national phase.

Flexibility in country selection

Paris route:

Low flexibility after the 12-month window.
Best when you already know the right countries.

PCT route:

Higher flexibility because you decide countries later.
Useful when the business is still learning.

Speed to local examination and grant

Paris route:

Often faster local examination start in chosen countries, because filings are earlier.

PCT route:

Often later local start because national filings happen later.
Still can be effective if speed to grant is not the priority.

Practical takeaway

Paris route tends to favor speed and early commitment. PCT route tends to favor flexibility and staged spending. The “better” option depends on what your business needs most right now.
Key timeline checkpoints

Milestone	Paris route	PCT route	Founder note
Priority date set	First filing date	First filing date	This date anchors all foreign filing deadlines.
Foreign filing decision	By month 12	Country selection later	If you can’t justify countries by month 12, PCT helps.
Main cost spike	Within 12 months if multiple countries	At national phase entry	Plan funding/traction milestones around the spike.
Local examination starts	Earlier in filed countries	Often later (post national phase)	Choose based on whether early local progress matters.

Country strategy: how your target markets change the choice

Start with the countries that matter commercially

A foreign filing strategy should follow business reality:

where customers will pay
where the buying decision happens
where you will manufacture or source
where competitors operate and can scale copying

If you can confidently list your top 2–5 countries, Paris route becomes easier to justify. If you cannot, PCT route often protects you from guessing too early.

When Paris route is often a good match

Paris route usually fits better when:

your top markets are clear and limited
You are not trying to keep 15 options open.
you are entering those markets soon
Patents are meant to support a real market plan, not a wish list.
you need earlier local progress
For example, you anticipate procurement, licensing, or enterprise diligence in those countries.
manufacturing risk is not the main driver
Or manufacturing is already in the same country list.

When PCT route is often a better match

PCT route tends to fit better when:

you are unsure which markets will become revenue markets
Especially true for early platform products and new categories.
the market may expand in unpredictable ways
Partners and distribution can shift your geography.
you need time to decide whether manufacturing countries should be included
This is common when contract manufacturing or scaling plans are not final.
you want to avoid wasting money on low-leverage countries
Many startups later realize that only a few markets really matter.

A simple way to build your country list

Create two lists:

Core markets: where you expect meaningful revenue in 12–36 months.
Risk markets: where copying can scale (manufacturing hubs) or where key competitors are.

If both lists are short and stable, Paris route becomes easier. If both lists are uncertain, PCT route usually gives you better decision time.

Country shortlist builder

Country/Region	Revenue market (H/M/L)	Manufacturing/copy risk (H/M/L)	Competitor presence (H/M/L)	Enforcement/deterrence practical? (H/M/L)	One-sentence reason

Tip: keep 2–5 countries as “core” and 2–3 as “optional,” tied to milestones.

Practical takeaway

Country strategy should not be driven by “big economies.” It should be driven by where the business will win or lose. Your filing route should support that country strategy.

Technology and business model fit

Why the product type affects route choice

Some inventions need quick local progress. Others benefit more from flexibility. Your business model and technology shape what “value” from patents looks like.

SaaS and software-led products

In many software businesses:

defensibility often comes from execution, data, distribution, and switching costs
patents may still help, but the country list may be smaller
the invention may evolve rapidly in early stages

PCT route is often considered when the product is still evolving and markets are uncertain. Paris route can make sense when you have a clear enterprise market and a stable technical mechanism worth protecting.

Hardware and manufacturing-heavy products

In hardware:

copying can be faster once the product is in the market
supply chain and manufacturing geography matter
enforcement and deterrence can be more relevant

Paris route can be useful when you already know your key markets and want earlier local filings. PCT route can be useful when you want to delay the major multi-country cost until you confirm manufacturing plans and market pull.

Deeptech and platform technologies

For deeptech (materials, semiconductors, core algorithms, infrastructure):

patents often play a central defensibility role
licensing and partnerships can be important
strong claim strategy and country planning matter

PCT route is often used to preserve options while refining claim strategy and commercial roadmap. Paris route can be used if key jurisdictions are clear and speed matters for deals.

Regulated industries (medtech, pharma, aerospace, telecom)

Regulation can change timing:

approvals may force technical disclosure in tenders or certifications
market entry timelines may be long
buyer trust and compliance can amplify defensibility

If disclosure risk is high and markets are clear, Paris route may be attractive to start local timelines early. If timelines are long and the product will evolve during trials, PCT route can allow staged decision-making and better claim alignment.

Practical takeaway

Your route should match how your business wins:

If speed in specific markets matters, Paris route often aligns.
If flexibility, staged spending, and evolving scope matter, PCT route often aligns.

Common scenarios and recommended route

Scenario 1: “We know our top 3 markets already.”

This is common when you already sell in certain countries, have signed LOIs, or your buyer segment is concentrated in a few regions.

What usually fits:

Paris route often fits well because you can choose countries early and start local filings sooner.
PCT can still fit if you want extra time, but it may be less necessary if the country list is stable.

Questions to ask:

Are these markets likely to remain the top markets in 18–24 months?
Do we have budget to file in these countries within 12 months?
Would earlier local filings help sales, procurement, or partnerships?

Scenario 2: “We need more time to validate before committing.”

This is common when your product is still evolving or your market is still being discovered.

What usually fits:

PCT route often fits because it delays the biggest multi-country spend while keeping options open.
A lean Paris approach can still work if you choose only 1–2 countries and keep the rest for later, but it increases the risk of “wrong country” choices.

Questions to ask:

What milestones will make our market and country choices clearer?
Are we actively using the extra time for validation, or just postponing decisions?

Scenario 3: “We are fundraising in 6 months.”

Fundraising itself does not require one specific route, but it often affects the story you want to tell.

What usually fits:

PCT route can signal international intent while preserving flexibility.
Paris route can signal focus if you filed in exactly the markets your investors care about.

Questions to ask:

Will investors value optionality (PCT) or clear market focus (Paris)?
Can we explain why each country on our list matters?

Scenario 4: “A competitor is moving fast.”

Speed matters most when the competitor is strong in a specific geography and copying risk is real.

What usually fits:

Paris route can be practical if you need early local filings in key markets.
PCT route can still work, but you should have a clear plan for which countries you will enter later.

Questions to ask:

Where will the competitor copy and sell first?
Is enforcement or deterrence meaningful in those countries?

Scenario 5: “We plan to license, partner, or do joint ventures.”

Licensing discussions often depend on clarity of scope and country coverage aligned to markets.

What usually fits:

PCT route often fits early because it preserves broad options while you test licensing interest.
Paris route may fit if you already know which countries the licensee will require.

Questions to ask:

Where would a potential licensee make or sell the product?
Is licensing realistic in the next 12–24 months, or still speculative?

Common scenarios and typical route fit

Scenario	Usually fits better	Why	Watch-outs
Top 3 markets are known and stable	Paris	Early filing in chosen countries starts local timelines sooner	Don’t over-expand country list without a clear reason
Markets still uncertain; product evolving	PCT	More time before committing to expensive country filings	Use extra time actively; don’t postpone decisions without work
Fundraising soon; need “international intent”	PCT (often)	Signals optionality without forcing early country commitments	Investors still expect a credible country strategy
Competitor pressure in a known market	Paris (often)	Earlier local filing in that market can matter	Ensure invention scope is strong and stable
Licensing/partner-led expansion	PCT (often)	Preserves flexibility until partner geography is confirmed	Don’t keep too many options alive past milestones

Practical takeaway

The route should match how certain you are about the market and how urgently you need local progress in specific countries. If you are still learning, flexibility usually wins. If you already know your markets and need speed, early country filings often make sense.

Cost planning (founder-friendly)

Why cost planning matters early

Many founders budget only for the initial filing, then get surprised later. Foreign filing costs usually come in waves and can be difficult to “pause” once deadlines arrive.

The important decision is not just which route is cheaper. The decision is which route matches your cashflow and milestones.

The main cost components to expect

Both routes involve:

attorney and drafting costs for the initial application
filing fees and official fees
translation costs in certain jurisdictions
local counsel costs in each chosen country
future prosecution costs (responses to office actions, amendments)
renewals/annuities over time

How the Paris route tends to behave on cost

In Paris route:

you face multi-country spend earlier, within the 12-month window
costs may rise quickly if you select many jurisdictions
prosecution timelines start earlier in each selected country, so costs may begin sooner

Paris route works best when your country list is limited and intentional.

How the PCT route tends to behave on cost

In PCT route:

you add the PCT step cost, but delay the larger multi-country filing costs
the biggest cost spike often comes at national phase entry
prosecution costs are pushed later, which can align better with fundraising or revenue

PCT route works best when you plan to use the extra time to narrow countries and strengthen the case for each one.

A simple budgeting discipline that prevents regret

Before choosing a route, decide:

the maximum number of countries you are willing to pursue
what “success” milestone triggers national phase entry or wider coverage
what “lack of traction” milestone triggers narrowing or dropping countries
whether you can afford prosecution and renewals, not just filing

Practical takeaway

If you are early-stage and unsure, PCT often helps you delay the biggest spend. If you are confident and need earlier action in specific countries, Paris can be efficient, but only if your list stays tight.

Risk management

Why risk management should guide route choice

The biggest errors in foreign filing are usually not legal errors. They are planning errors:

missing deadlines
disclosing too much before filing
choosing countries without a strategy
spending money in jurisdictions that never become relevant

Risk management helps you choose a route that reduces these mistakes.

Public disclosure risks

Both routes are vulnerable to early disclosure, because novelty can be lost if you disclose before filing (depending on the country and circumstances).

Common disclosure points:

investor decks shared widely
public product launches, demos, webinars
publications, preprints, conferences
open-source releases
pilot projects where details become visible

Practical rule:

treat “anything outside your team” as a potential disclosure, unless controlled.

Priority and deadline risks

Paris route:

the 12-month deadline is critical, and missing it can remove your ability to claim priority abroad.
you must make country decisions fast, which can lead to rushed choices.

PCT route:

still requires action within 12 months to file the PCT.
later deadlines (national phase) still need planning, but you gain time.

Translation and formalities risks

Translation requirements can drive cost, timelines, and error risk.

some countries require translations at filing or national phase
errors or inconsistency can complicate prosecution
delaying translation through PCT can reduce rushed work, but does not remove it

Strategy risks (the hidden ones)

“Too many countries” risk
A long list often becomes impossible to maintain.
“Wrong countries” risk
Filing where you do not sell, manufacture, or face competitors wastes money.
“Weak scope” risk
Filing too narrow or too close to one implementation can be designed around.

Risk checklist and mitigation

Risk	Where it shows up	Impact	Simple mitigation
Missed deadlines	Priority year, national phase	Loss of rights or costly workarounds	Create a filing calendar on day 1; assign an owner
Public disclosure before filing	Demos, decks, GitHub, publications	Novelty loss in key jurisdictions	Disclosure rules + “file before launch” discipline
Wrong country selection	Early Paris filings	Wasted spend, hard-to-maintain portfolio	Use the country shortlist builder; justify each country
Over-filing (too many countries)	Both routes	Budget stress, forced abandonments	Cap core countries; stage optional markets via milestones
Narrow/weak scope	Initial drafting	Easy design-around	Draft variations and fallbacks; map design-around paths

Practical takeaway

Choose the route that reduces your biggest risk:

If your risk is rushed country selection, PCT often helps.
If your risk is competitor pressure in a known market, Paris may help.
In both cases, disciplined disclosure control and deadline tracking are essential.

Decision tools

Tool 1: The 8-question route selector

Route selector scorecard

Question	Leans Paris if “Yes”	Leans PCT if “Yes”
We know the top 2–5 revenue countries within 24 months	Yes
We need early local filings for deals, tenders, or regulation	Yes
We can fund multi-country filings within 12 months	Yes
The invention scope is stable enough to commit now	Yes
We need more time to validate markets before choosing countries		Yes
Budget is better staged after milestones (revenue/fundraise)		Yes
Partners/distribution may change our market geography		Yes
We want to avoid committing to a country list too early		Yes

How to use: if most “Yes” answers fall in the Paris column, Paris route is often a better fit. If most “Yes” answers fall in the PCT column, PCT route is often a better fit.

Tool 2: The one-sentence test

Complete this sentence clearly:

We should choose [Paris / PCT] because we need protection in [countries] by [time], and we will use that protection to support [business outcome], while keeping spend aligned to [milestone].

If you cannot complete this sentence without guessing, your strategy may be “not yet,” or you may need the PCT route to gain decision time.

Tool 3: Go / No-go / Not-yet

Go now when:

markets are clear and important
copying risk is high and harmful
invention scope is stable
budget exists for follow-through

Not-yet when:

markets are still being discovered
the product may pivot
budgets are tight, but likely to improve after milestones
you need more competitor or market clarity

No-go when:

patents will not change outcomes
differentiation is execution, distribution, or brand
you cannot maintain filings and prosecution realistically

Practical takeaway

The right route is the one you can execute well with discipline. If you will not track deadlines, manage disclosures, and stage spend, even the best strategy becomes expensive noise.

Next steps

What to do right now

Pick one of these starting points:

If you already know your top countries and need earlier local progress, start planning a Paris route country list and budget.
If you need more time to validate markets or stage spending, plan the PCT route and use the extra time for structured decision-making.

Whichever route you choose, two disciplines matter most:

control public disclosure until filings are safely made
track deadlines early so you don’t end up rushing decisions

What to prepare before you speak to counsel

Bring a short, practical packet. It does not need to be perfect.

A one-page invention summary (problem, solution, what’s new, why it matters)
A sketch or simple diagram of how it works (even a rough flow is fine)
A list of variations and fallbacks (at least 3 ways the invention could be implemented)
Your top 3–5 target countries and why each one matters
Your top 5 competitors and how you think they would copy or design around
Any upcoming disclosure events (demo day, launch, paper, webinar, GitHub release)

A 30-day action plan

Week 1: Clarify scope and disclosure

write a clear invention summary and version map
identify what you will disclose in fundraising and demos
set internal rules for what can be shared and when

Week 2: Build country logic

list likely revenue markets (12–36 months)
list manufacturing or copying-risk markets
shortlist 2–5 “core countries” and 2–3 “optional countries”

Week 3: Decide route using real constraints

confirm whether the country list is stable enough for Paris route
if not stable, consider PCT route and plan how you’ll use the extra time
draft a simple budget rule: what triggers more spend, what triggers narrowing

Week 4: Execute filings and deadline tracking

finalize the route and filing calendar
ensure the first filing is drafted with variations and fallback versions
create a simple system to track deadlines and decision points

FAQs

Can I use both Paris route and PCT route?

Yes, in some strategies you can file in select countries directly and also file a PCT within the priority year. This can increase cost and complexity, so it’s usually done when there’s a clear reason (for example, you need early local filing in one country but still want broader optionality elsewhere).

Is PCT always cheaper than Paris route?

Not always. PCT can delay major costs, but it adds its own cost. It is often chosen for better timing and flexibility rather than being strictly “cheaper.”

If I only want 2–3 countries, should I still do PCT?

Often, if your country list is truly stable and small, direct filings via the Paris route can be simpler. PCT tends to add value when you want more time, more optionality, or you are still uncertain about the final country set.

What if we miss the 12-month priority deadline?

You may lose the ability to claim that priority date in many jurisdictions, which can significantly reduce your options. Treat the 12-month deadline as a non-negotiable planning anchor and track it early.

Do I need a granted patent quickly?

Sometimes, but not always. If a deal, tender, licensing discussion, or regulatory pathway needs earlier local progress, Paris route can help by starting local timelines sooner in chosen countries. If the main goal is flexibility while you validate, PCT can be more aligned.

If you want, I can also add a short, printable “Route Decision Worksheet” (one page) that teams can fill internally before calling counsel.